DZ2649A1 - Association of active principles for the treatment of senile dementia of the alzheimer type. - Google Patents
Association of active principles for the treatment of senile dementia of the alzheimer type.Info
- Publication number
- DZ2649A1 DZ2649A1 DZ980259A DZ980259A DZ2649A1 DZ 2649 A1 DZ2649 A1 DZ 2649A1 DZ 980259 A DZ980259 A DZ 980259A DZ 980259 A DZ980259 A DZ 980259A DZ 2649 A1 DZ2649 A1 DZ 2649A1
- Authority
- DZ
- Algeria
- Prior art keywords
- association
- treatment
- senile dementia
- active principles
- alzheimer type
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 206010039966 Senile dementia Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9714322A FR2771007B1 (en) | 1997-11-14 | 1997-11-14 | COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE |
| FR9714324A FR2771006B1 (en) | 1997-11-14 | 1997-11-14 | COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DZ2649A1 true DZ2649A1 (en) | 2004-12-28 |
Family
ID=26233932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DZ980259A DZ2649A1 (en) | 1997-11-14 | 1998-11-11 | Association of active principles for the treatment of senile dementia of the alzheimer type. |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP1030671A1 (en) |
| JP (1) | JP2001523642A (en) |
| KR (1) | KR100599350B1 (en) |
| CN (1) | CN1243540C (en) |
| AU (1) | AU743228B2 (en) |
| BG (1) | BG64819B1 (en) |
| BR (1) | BR9814035A (en) |
| CA (1) | CA2309966A1 (en) |
| CO (1) | CO4980891A1 (en) |
| DZ (1) | DZ2649A1 (en) |
| EA (1) | EA003255B1 (en) |
| EE (1) | EE04235B1 (en) |
| HU (1) | HUP0100098A3 (en) |
| ID (1) | ID24933A (en) |
| IL (2) | IL136122A0 (en) |
| IS (1) | IS5482A (en) |
| MY (1) | MY120461A (en) |
| NO (1) | NO20002450L (en) |
| NZ (1) | NZ504420A (en) |
| OA (1) | OA11464A (en) |
| PL (1) | PL194597B1 (en) |
| SA (1) | SA98190747B1 (en) |
| SK (1) | SK286040B6 (en) |
| TR (1) | TR200001262T2 (en) |
| TW (1) | TW585766B (en) |
| UY (1) | UY25247A1 (en) |
| WO (1) | WO1999025363A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE42327E1 (en) * | 2002-06-14 | 2011-05-03 | Toyama Chemical Co., Ltd. | Medicinal compositions improving brain function and method for improving brain function |
| AU2003266967B2 (en) * | 2002-08-07 | 2006-11-16 | Novartis Ag | Methods for the treatment of dementia based on Apo E genotype |
| CN1520818A (en) * | 2003-02-09 | 2004-08-18 | 山东绿叶天然药物研究开发有限公司 | Cholinesterase inhibitor pharmaceutical composition for senile dementia |
| EP1830886B1 (en) | 2004-12-27 | 2016-04-13 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
| DK3099296T3 (en) | 2014-01-31 | 2019-04-15 | Cognition Therapeutics Inc | ISO-INDOLINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE |
| KR102614814B1 (en) | 2017-05-15 | 2023-12-20 | 카그니션 테라퓨틱스, 인코퍼레이티드 | Composition for treating neurodegenerative diseases |
| KR102224918B1 (en) | 2018-03-20 | 2021-03-09 | (주)인벤티지랩 | Pharmaceutiical composition comprising memantine and donepezil for preventing or treating cognitive impairment-related disease and preparation method thereof |
| WO2019182319A1 (en) * | 2018-03-20 | 2019-09-26 | (주)인벤티지랩 | Method for preparing pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, and pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, prepared by preparation method |
| CN109265391B (en) * | 2018-11-13 | 2021-11-19 | 枣庄学院 | Biphenyl polysubstituted 1,2,5, 6-tetrahydropyridine compound and synthetic method and application thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2662355B1 (en) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | USE OF 1- [2- (2-NAPHTYL) ETHYL] -4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETRAHYDROPYRIDINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF BRAIN AND NEURAL DISORDERS. |
| US5453428A (en) * | 1991-02-14 | 1995-09-26 | The Mount Sinai School Of Medicine Of The City Of New York | Method and composition for the treatment of apathy-amotivation syndrome |
| CA2213000A1 (en) * | 1995-03-06 | 1996-09-12 | Interneuron Pharmaceuticals, Inc. | Reduction of infarct volume using citicoline |
| FR2736053B1 (en) * | 1995-06-28 | 1997-09-19 | Sanofi Sa | NEWS 1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES |
-
1998
- 1998-10-26 CO CO98062479A patent/CO4980891A1/en unknown
- 1998-10-28 TW TW087117874A patent/TW585766B/en not_active IP Right Cessation
- 1998-11-09 KR KR1020007005231A patent/KR100599350B1/en not_active Expired - Fee Related
- 1998-11-09 TR TR2000/01262T patent/TR200001262T2/en unknown
- 1998-11-09 WO PCT/FR1998/002384 patent/WO1999025363A1/en not_active Ceased
- 1998-11-09 CN CNB988130947A patent/CN1243540C/en not_active Expired - Fee Related
- 1998-11-09 IL IL13612298A patent/IL136122A0/en not_active IP Right Cessation
- 1998-11-09 PL PL98340500A patent/PL194597B1/en not_active IP Right Cessation
- 1998-11-09 AU AU11609/99A patent/AU743228B2/en not_active Ceased
- 1998-11-09 JP JP2000520796A patent/JP2001523642A/en not_active Withdrawn
- 1998-11-09 CA CA002309966A patent/CA2309966A1/en not_active Abandoned
- 1998-11-09 NZ NZ504420A patent/NZ504420A/en unknown
- 1998-11-09 EE EEP200000290A patent/EE04235B1/en not_active IP Right Cessation
- 1998-11-09 HU HU0100098A patent/HUP0100098A3/en unknown
- 1998-11-09 BR BR9814035-3A patent/BR9814035A/en not_active Application Discontinuation
- 1998-11-09 SK SK711-2000A patent/SK286040B6/en unknown
- 1998-11-09 ID IDW20000860A patent/ID24933A/en unknown
- 1998-11-09 EP EP98954538A patent/EP1030671A1/en not_active Withdrawn
- 1998-11-09 EA EA200000412A patent/EA003255B1/en not_active IP Right Cessation
- 1998-11-11 DZ DZ980259A patent/DZ2649A1/en active
- 1998-11-12 UY UY25247A patent/UY25247A1/en not_active IP Right Cessation
- 1998-11-14 SA SA98190747A patent/SA98190747B1/en unknown
- 1998-11-14 MY MYPI98005180A patent/MY120461A/en unknown
-
2000
- 2000-05-09 IS IS5482A patent/IS5482A/en unknown
- 2000-05-11 BG BG104428A patent/BG64819B1/en unknown
- 2000-05-11 NO NO20002450A patent/NO20002450L/en unknown
- 2000-05-12 OA OA1200000141A patent/OA11464A/en unknown
- 2000-05-14 IL IL136122A patent/IL136122A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0670731A4 (en) | TREATMENT OF AMNESIA IN ALZHEIMER'S DISEASE CAUSED BY THE DEPOSITION OF AMYLOID G (B) PROTEIN. | |
| ATE279407T1 (en) | FSH MIMETICS FOR THE TREATMENT OF INFERTILITY | |
| DZ3014A1 (en) | Medicines for the treatment of hypertension. | |
| FR2718351B1 (en) | Process for the permanent deformation of keratin materials. | |
| FR2721823B1 (en) | Process for the permanent deformation of keratin materials | |
| DZ2649A1 (en) | Association of active principles for the treatment of senile dementia of the alzheimer type. | |
| FR2705966B1 (en) | Antifoam compositions useful in particular for the treatment of gastric disorders. | |
| DE69607728D1 (en) | Thixo casting process | |
| PH31643A (en) | 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease. | |
| FR2694575B1 (en) | PROCESS FOR THE TREATMENT OF MCRALZ COATINGS. | |
| DZ2012A1 (en) | Benzamides for the treatment of neurological degenerations. | |
| MA25852A1 (en) | METHOD FOR THE TREATMENT OF INFLAMMATION. | |
| FR2719240B1 (en) | Process for the treatment of oily suspensions. | |
| FR2713657B1 (en) | New vectors for the treatment of AIDS. | |
| EP0667157A4 (en) | SYMPTOMATIC TREATMENT OF CIRCULATORY DISORDERS. | |
| FR2771006B1 (en) | COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE | |
| FR2771007B1 (en) | COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE | |
| DE60201440D1 (en) | ARYL-8-AZABICYCLO [3.2.1] OCTANES FOR THE TREATMENT OF DEPRESSION | |
| ATE345818T1 (en) | S-METHYL-DIHYDRO-ZIPRASIDONE FOR THE TREATMENT OF PSYCHIATRIC DISORDERS. | |
| FR2716803B1 (en) | Process for the permanent deformation of keratin materials. | |
| IT1281347B1 (en) | SELF-STEERING RODIGGIO FOR ROTABILI ON IRON | |
| FR2694748B1 (en) | Decanter-digester for the treatment of domestic waste water. | |
| FR2702645B1 (en) | ADAPTABLE BATHTUB FOR BATHROOM. | |
| FR2804331B1 (en) | VALVE FOR THE TREATMENT OF HYDROCEPHALIA | |
| FR2706307B1 (en) | Formula for treatment of AIDS. |